About Quomics
Pioneering quantum-powered drug discovery to revolutionize cancer treatment.
Our Mission
At Quomics, we are reimagining oncology drug discovery using quantum computing, AI, and cloud-based wet lab integration. Our goal is to identify breakthrough cancer therapeutics with unprecedented speed and precision.
By leveraging quantum-enhanced molecular simulations, we uncover new peptide and small-molecule drug candidates faster than traditional methods, significantly reducing both costs and time-to-market.
Founding Story
Quomics was founded by Alexander Wormuth, whose personal journey with cancer has shaped his mission. Inspired by his mother battling colon cancer, Alexander recognized the tremendous opportunity to accelerate innovation in cancer treatment, an area that has seen gradual progress over the past 30 years.
With a background in computer science and extensive industry experience, Alexander has dedicated his life to accelerating cancer research through the revolutionary potential of quantum computing.
Today, Alexander is driven by a deeply personal vision: to create a world where his son can grow up without the shadow of cancer. This vision of a cancer-free future for the next generation fuels Quomics' relentless pursuit of breakthrough therapies.
Our Approach
Quantum-Powered Drug Discovery
We leverage quantum computing to simulate molecular interactions at atomic precision, identifying novel drug candidates that traditional methods overlook.
AI-Enhanced Molecular Design
Our proprietary AI models analyze complex biological data, accelerating lead optimization and reducing failure rates in clinical development.
Cloud-Based Wet Lab Validation
Through seamless integration with cloud labs, we validate computational predictions with automated biochemical and cellular assays.
Collaborating with Biotech & Academia
We partner with research labs and biotech startups to bring innovative therapies to market faster, improving patient outcomes.
Join Our Mission
We're looking for partners, biotech companies, and researchers who share our vision of revolutionizing cancer treatment. Get in touch to explore collaboration opportunities.